Screener
Gilead Sciences GILD Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Gilead Sciences’s reported figures.
Based on trailing twelve months.
The source filing: Gilead Sciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000882095-26-000024
FAQ
- What is Gilead Sciences's return on equity?
- Gilead Sciences (GILD) reported return on equity of 43.2% in Q1 2026.
- How has Gilead Sciences's return on equity changed year-over-year?
- Gilead Sciences's return on equity increased by 32.9% year-over-year, from 32.5% to 43.2%.
- What is the long-term trend for Gilead Sciences's return on equity?
- Over 5 years (2020 to 2025), Gilead Sciences's return on equity has grown at a 131.9% compound annual growth rate (CAGR), from 0.6% to 40.5%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Gilead Sciences's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude